Increased investment oversight, specialist asset allocation, timely execution and live client access from the convenience of a mobile phone.
These are just some of the benefits Endorphin Wealth’s clients are enjoying since the launch of its Managed Discretionary Account (MDA) service.
Endorphin Wealth recently added its MDA to an already impressive range of advisory services, much to the excitement of Endorphin director Phillip Richards.
Endorphin’s MDA service is the product of a collaboration between investment consultant Oreana Portfolio Advisory Services, licensee Lifespan Financial Planning and platform provider BT Financial Group.
Mr Richards says provides Endorphin clients with significant additional investment experience and oversight, as well as exceptional technological capabilities.
“We are really excited to be able to bring this service to our clients and the market,” Mr Richards said.
“We believe the collaborators we have brought together to make this MDA possible, coupled with our excellent in-house advisory skill set will enable Endorphin to achieve outstanding results for our clients.”
Mr Richards said that in a time of relative uncertainty in the financial markets, the ability to act quickly was key to achieving positive outcomes for Endorphin’s clients.
At the same time, the added layers of advice and governance provided by the MDA’s collaborators meant that speed never comes at the cost of rigour.
“The take-up of this service from our clients has been extremely positive,” Mr Richards said.
“The positivity around the extra capability this brings us as their advisers have been well received.
“They are getting a whole new level of detail when it comes to how assets are allocated with the additional insights and reporting from Oreana, and they can see everything in real-time through the BT Panorama mobile app.
“And they’re getting this for essentially the same management fees they were already paying.”
The MDA offers a range of investment portfolios catering to different client strategies, objectives and risk profiles.
Lifespan CEO Eugene Ardino said he was happy to be able to support the firm on this next step of its development.
“Endorphin is one of our bigger and faster-growing firms,” he said.
“We think the main benefits of an MDA to the client are that they enable the adviser to provide a much more efficient and active portfolio management service.
“There are essentially three layers of review for everything, from the asset allocation to the fund managers and as licensee part of our role is to work with Oreana.
“Endorphin will also review all asset allocations as well, so there are several layers of review which I think provides quite a thorough and comprehensive service that is well set-up to provide optimal outcomes from the clients.”
Oreana Head of Portfolio Advisory Shane Hawke said he too was excited by the collaboration.
“There’s a clear professional and passionate approach to improving client outcomes from all parties,” he said.
Oreana brings a wealth of investment experience to the table, with CEO Luke Moore having previously been head of National Australia Bank (NAB)’s Private Wealth Advisory capability across Asia.
Oreana also boasts the considerable expertise of Chief Investment Officer, Dr Isaac Poole, whose considerable experience includes prior roles at such as Chief Economist at NSW Treasury Corporation and Willis Towers Watson as the Head of Capital Markets Research in the Asia-Pacific.
Hawke said that Oreana’s investment experience, coupled with its strong investment governance, would help Endorphin and their clients achieve their goals.
“Our investment strategy applies a fundamental valuation-based approach that brings together strategic allocation, dynamic asset allocation and manager selection to optimise risk-adjusted returns.
“I think the key element here is Endoprhin’s desire to meet their client’s goals and recognising that they need to introduce additional support to fulfil that.
“From Oreana’s perspective, we believe our investment expertise and investment governance are quite important to success.”
Chris Mather, Head of Distribution at BT Financial Group, said it was fantastic to be working with three specialists in their areas of expertise.
“When specialists come together like this, it means better focus and better risk management that delivers better outcomes for clients,” he said.
“BT is the custodian of the assets in the MDA, and we also provide the front-end experience to different parties.
“Our role is allowing the different people involved, from the client to the adviser to the licensees to connect and ensure the end client can see how their investments are working, what changes are made in terms of asset allocation, reporting and more.
“It means there is no lag time between the idea and execution, and we’re happy to be providing the architecture and play our part in helping Endorphin make this MDA possible.”
More information on each collaborator can be found at:
The team at Endorphin Wealth Management is happy to assist with helping clients achieve a positive outlook on their financial situation.
For an obligation free discussion, contact Endorphin Wealth at 03 9190 8964, or schedule a meeting at endorphinwealth.com.au/contact/
Dr Isaac Poole CIMA®, Oreana Chief Investment Officer
Endorphin Wealth collaborates with Oreana Portfolio Advisory Services under the expertise of Dr. Isaac Pole whose prior roles included Head of Capital Markets Research at Willis Towers Watson, and Chief Economist at NSW Treasury Corporation. Oreana’s investment expertise and strong investment governance would help Endorphin wealth and its clients achieve their financial goals.